Berlin-based digital healthcare start-up Myosotis GmbH (myo) has received €10.5m (£9m) investment to help grow its business in Germany, Austria, Switzerland (DACH region) and UK. TVM Capital Life Science, a transatlantic venture capital firm focused on investments in life sciences innovation, led the Series A financing round for myo with €8m, with the funds being…
Membership Required
You must be a CM Subscriber to view this content.
Already have an account? Sign In
©2024 All rights reserved LaingBuisson 
 has received €8m (£6.8m) investment to help grow its business in Germany, Austria, and Switzerland (DACH region) and UK.){kind=link}